Literature DB >> 23766104

Genetic abnormalities in FOXP1 are associated with congenital heart defects.

Sheng-Wei Chang1, Mona Mislankar, Chaitali Misra, Nianyuan Huang, Daniel G Dajusta, Steven M Harrison, Kim L McBride, Linda A Baker, Vidu Garg.   

Abstract

The etiology for the majority of congenital heart defects (CHD) is unknown. We identified a patient with unbalanced atrioventricular septal defect (AVSD) and hypoplastic left ventricle who harbored an ~0.3 Mb monoallelic deletion on chromosome 3p14.1. The deletion encompassed the first four exons of FOXP1, a gene critical for normal heart development that represses cardiomyocyte proliferation and expression of Nkx2.5. To determine whether FOXP1 mutations are found in patients with CHD, we sequenced FOXP1 in 82 patients with AVSD or hypoplastic left heart syndrome. We discovered two patients who harbored a heterozygous c.1702C>T variant in FOXP1 that predicted a potentially deleterious substitution of a highly conserved proline (p.Pro568Ser). This variant was not found in 287 controls but is present in dbSNP at a 0.2% frequency. The orthologous murine Foxp1 p.Pro596Ser mutant protein displayed deficits in luciferase reporter assays and resulted in increased proliferation and Nkx2.5 expression in cardiomyoblasts. Our data suggest that haploinsufficiency of FOXP1 is associated with human CHD.
© 2013 WILEY PERIODICALS, INC.

Entities:  

Keywords:  FOXP1; atrioventricular septal defect; cardiomyocyte; hypoplastic left heart syndrome

Mesh:

Substances:

Year:  2013        PMID: 23766104      PMCID: PMC5717756          DOI: 10.1002/humu.22366

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  26 in total

1.  Modifying Mendel: approaches for identification of susceptibility alleles for human cardiovascular malformations.

Authors:  Kim L McBride; Stephanie M Ware
Journal:  Circ Cardiovasc Genet       Date:  2012-06

2.  Foxp1 coordinates cardiomyocyte proliferation through both cell-autonomous and nonautonomous mechanisms.

Authors:  Yuzhen Zhang; Shanru Li; Lijun Yuan; Ying Tian; Joel Weidenfeld; Jifu Yang; Feiyan Liu; Ann L Chokas; Edward E Morrisey
Journal:  Genes Dev       Date:  2010-08-15       Impact factor: 11.361

3.  The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p.

Authors:  A H Banham; N Beasley; E Campo; P L Fernandez; C Fidler; K Gatter; M Jones; D Y Mason; J E Prime; P Trougouboff; K Wood; J L Cordell
Journal:  Cancer Res       Date:  2001-12-15       Impact factor: 12.701

4.  Submicroscopic chromosomal copy number variations identified in children with hypoplastic left heart syndrome.

Authors:  Ashleigh R Payne; Sheng-Wei Chang; Sara N Koenig; Andrew R Zinn; Vidu Garg
Journal:  Pediatr Cardiol       Date:  2012-02-21       Impact factor: 1.655

5.  Loss of function and inhibitory effects of human CSX/NKX2.5 homeoprotein mutations associated with congenital heart disease.

Authors:  H Kasahara; B Lee; J J Schott; D W Benson; J G Seidman; C E Seidman; S Izumo
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

Review 6.  Insights into the genetic basis of congenital heart disease.

Authors:  V Garg
Journal:  Cell Mol Life Sci       Date:  2006-05       Impact factor: 9.261

Review 7.  3p interstitial deletion: novel case report and review.

Authors:  Andreea Cristina Ţuţulan-Cunită; Sorina Mihaela Papuc; Aurora Arghir; Katharina Magdalena Rötzer; Charulata Deshpande; Agripina Lungeanu; Magdalena Budişteanu
Journal:  J Child Neurol       Date:  2012-01-30       Impact factor: 1.987

8.  GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5.

Authors:  Vidu Garg; Irfan S Kathiriya; Robert Barnes; Marie K Schluterman; Isabelle N King; Cheryl A Butler; Caryn R Rothrock; Reenu S Eapen; Kayoko Hirayama-Yamada; Kunitaka Joo; Rumiko Matsuoka; Jonathan C Cohen; Deepak Srivastava
Journal:  Nature       Date:  2003-07-06       Impact factor: 49.962

9.  A 785kb deletion of 3p14.1p13, including the FOXP1 gene, associated with speech delay, contractures, hypertonia and blepharophimosis.

Authors:  Mitchel J Pariani; Andrew Spencer; John M Graham; David L Rimoin
Journal:  Eur J Med Genet       Date:  2009-03-28       Impact factor: 2.708

10.  GATA4 sequence variants in patients with congenital heart disease.

Authors:  A Tomita-Mitchell; C L Maslen; C D Morris; V Garg; E Goldmuntz
Journal:  J Med Genet       Date:  2007-12       Impact factor: 6.318

View more
  23 in total

Review 1.  Congenital cardiac anomalies and white matter injury.

Authors:  Paul D Morton; Nobuyuki Ishibashi; Richard A Jonas; Vittorio Gallo
Journal:  Trends Neurosci       Date:  2015-05-01       Impact factor: 13.837

2.  Disruption of myocardial Gata4 and Tbx5 results in defects in cardiomyocyte proliferation and atrioventricular septation.

Authors:  Chaitali Misra; Sheng-Wei Chang; Madhumita Basu; Nianyuan Huang; Vidu Garg
Journal:  Hum Mol Genet       Date:  2014-05-08       Impact factor: 6.150

3.  Utilization of Whole Exome Sequencing to Identify Causative Mutations in Familial Congenital Heart Disease.

Authors:  Stephanie LaHaye; Don Corsmeier; Madhumita Basu; Jessica L Bowman; Sara Fitzgerald-Butt; Gloria Zender; Kevin Bosse; Kim L McBride; Peter White; Vidu Garg
Journal:  Circ Cardiovasc Genet       Date:  2016-07-14

4.  The transcription factor Foxc1a in zebrafish directly regulates expression of nkx2.5, encoding a transcriptional regulator of cardiac progenitor cells.

Authors:  Yunyun Yue; Mingyang Jiang; Luqingqing He; Zhaojunjie Zhang; Qinxin Zhang; Chun Gu; Meijing Liu; Nan Li; Qingshun Zhao
Journal:  J Biol Chem       Date:  2017-11-21       Impact factor: 5.157

5.  A novel NKX2.6 mutation associated with congenital ventricular septal defect.

Authors:  Juan Wang; Jian-Hui Mao; Ke-Ke Ding; Wei-Jun Xu; Xing-Yuan Liu; Xing-Biao Qiu; Ruo-Gu Li; Xin-Kai Qu; Ying-Jia Xu; Ri-Tai Huang; Song Xue; Yi-Qing Yang
Journal:  Pediatr Cardiol       Date:  2014-11-08       Impact factor: 1.655

6.  A Novel TBX1 Loss-of-Function Mutation Associated with Congenital Heart Disease.

Authors:  Yun Pan; Zha-Gen Wang; Xing-Yuan Liu; Hong Zhao; Ning Zhou; Gui-Fen Zheng; Xing-Biao Qiu; Ruo-Gu Li; Fang Yuan; Hong-Yu Shi; Xu-Min Hou; Yi-Qing Yang
Journal:  Pediatr Cardiol       Date:  2015-04-10       Impact factor: 1.655

7.  Epigenetic mechanisms underlying maternal diabetes-associated risk of congenital heart disease.

Authors:  Madhumita Basu; Jun-Yi Zhu; Stephanie LaHaye; Uddalak Majumdar; Kai Jiao; Zhe Han; Vidu Garg
Journal:  JCI Insight       Date:  2017-10-19

8.  miR-375-3p contributes to hypoxia-induced apoptosis by targeting forkhead box P1 (FOXP1) and Bcl2 like protein 2 (Bcl2l2) in rat cardiomyocyte h9c2 cells.

Authors:  Yuefan Li; Xiaofei Li; Ling Wang; Na Han; Gang Yin
Journal:  Biotechnol Lett       Date:  2020-10-30       Impact factor: 2.461

Review 9.  Genomics and Epigenomics of Congenital Heart Defects: Expert Review and Lessons Learned in Africa.

Authors:  Nicholas Ekow Thomford; Kevin Dzobo; Nana Akyaa Yao; Emile Chimusa; Jonathan Evans; Emmanuel Okai; Paul Kruszka; Maximilian Muenke; Gordon Awandare; Ambroise Wonkam; Collet Dandara
Journal:  OMICS       Date:  2018-05

10.  Heterozygous loss-of-function variants of MEIS2 cause a triad of palatal defects, congenital heart defects, and intellectual disability.

Authors:  Rosalind Verheije; Gabriel S Kupchik; Bertrand Isidor; Hester Y Kroes; Sally Ann Lynch; Lara Hawkes; Maja Hempel; Bruce D Gelb; Jamal Ghoumid; Guylaine D'Amours; Kate Chandler; Christèle Dubourg; Sara Loddo; Zeynep Tümer; Charles Shaw-Smith; Mathilde Nizon; Michael Shevell; Evelien Van Hoof; Kwame Anyane-Yeboa; Gaetana Cerbone; Jill Clayton-Smith; Benjamin Cogné; Pierre Corre; Anniek Corveleyn; Marie De Borre; Tina Duelund Hjortshøj; Mélanie Fradin; Marc Gewillig; Elizabeth Goldmuntz; Greet Hens; Emmanuelle Lemyre; Hubert Journel; Usha Kini; Fanny Kortüm; Cedric Le Caignec; Antonio Novelli; Sylvie Odent; Florence Petit; Anya Revah-Politi; Nicholas Stong; Tim M Strom; Ellen van Binsbergen; Koenraad Devriendt; Jeroen Breckpot
Journal:  Eur J Hum Genet       Date:  2018-10-05       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.